SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.

SOPHiA GENETICS SA

The latest announcement is out from SOPHiA GENETICS ( ($SOPH) ). On June 16, 2026, SOPHiA GENETICS entered into an underwriting agreement to sell 1...

SOPHiA GENETICS Raises $57.5 Million in June 2026 Share Offering

In a report released today, Mark Massaro from BTIG reiterated a Buy rating on SOPHiA GENETICS, with a price target of $8.00. Massaro covers the Hea...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SOPH	$5.68	-0.70%	120.86K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SOPH	$5.68	-0.7%	120.86K
3
4
5
6

SOPH

SOPH

Get SOPHiA GENETICS SA Data in Excel

Get SOPHiA GENETICS SA Data in Excel